학술논문

The PVT1 lncRNA is a novel epigenetic enhancer of MYC, and a promising risk-stratification biomarker in colorectal cancer
Document Type
article
Source
Molecular Cancer. 19(1)
Subject
Biomedical and Clinical Sciences
Oncology and Carcinogenesis
Genetics
Biotechnology
Digestive Diseases
Human Genome
Cancer
Colo-Rectal Cancer
Aetiology
2.1 Biological and endogenous factors
Biomarkers
Tumor
Colorectal Neoplasms
Enhancer Elements
Genetic
Epigenesis
Genetic
Gene Expression Regulation
Neoplastic
Humans
Prognosis
Proto-Oncogene Proteins c-myc
RNA
Long Noncoding
Survival Rate
PVT1
MYC
Enhancer
Epigenetic
Prognostic marker
Colorectal cancer
Oncology & Carcinogenesis
Biochemistry and cell biology
Oncology and carcinogenesis
Language
Abstract
Accumulating evidence suggests that dysregulation of transcriptional enhancers plays a significant role in cancer pathogenesis. Herein, we performed a genome-wide discovery of enhancer elements in colorectal cancer (CRC). We identified PVT1 locus as a previously unrecognized transcriptional regulator in CRC with a significantly high enhancer activity, which ultimately was responsible for regulating the expression of MYC oncogene. High expression of the PVT1 long-non-coding RNA (lncRNA) transcribed from the PVT1 locus was associated with poor survival among patients with stage II and III CRCs (p